These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 20729256)

  • 81. Uric acid in relapsing-remitting multiple sclerosis: a 2-year longitudinal study.
    Moccia M; Lanzillo R; Costabile T; Russo C; Carotenuto A; Sasso G; Postiglione E; De Luca Picione C; Vastola M; Maniscalco GT; Palladino R; Brescia Morra V
    J Neurol; 2015; 262(4):961-7. PubMed ID: 25673130
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Denial or unawareness of cognitive deficit associated with multiple sclerosis? A case report.
    Prigatano GP; Hendin BA; Heiserman JE
    J Clin Exp Neuropsychol; 2014; 36(4):335-41. PubMed ID: 24601906
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The utility of computerized neuropsychological assessment of cognitive dysfunction in patients with relapsing-remitting multiple sclerosis.
    Wilken JA; Kane R; Sullivan CL; Wallin M; Usiskin JB; Quig ME; Simsarian J; Saunders C; Crayton H; Mandler R; Kerr D; Reeves D; Fuchs K; Manning C; Keller M
    Mult Scler; 2003 Mar; 9(2):119-27. PubMed ID: 12708806
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Specificity of attention and cognitive inhibition processes in relapsing -remitting multiple sclerosis patients with consideration of their mood level].
    Tyburski E; Potemkowski A; Cheć M; Sołtys A; Mak M; Samochowiec A
    Psychiatr Pol; 2014; 48(2):307-18. PubMed ID: 25016768
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The effect of natalizumab on cognitive function in patients with relapsing-remitting multiple sclerosis: preliminary results of a 1-year follow-up study.
    Mattioli F; Stampatori C; Capra R
    Neurol Sci; 2011 Feb; 32(1):83-8. PubMed ID: 20872033
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Early putamen hypertrophy and ongoing hippocampus atrophy predict cognitive performance in the first ten years of relapsing-remitting multiple sclerosis.
    Morelli ME; Baldini S; Sartori A; D'Acunto L; Dinoto A; Bosco A; Bratina A; Manganotti P
    Neurol Sci; 2020 Oct; 41(10):2893-2904. PubMed ID: 32333180
    [TBL] [Abstract][Full Text] [Related]  

  • 87. A longitudinal study on fatigue, depression, and their relation to neurocognition in multiple sclerosis.
    Hildebrandt H; Eling P
    J Clin Exp Neuropsychol; 2014; 36(4):410-7. PubMed ID: 24702275
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Early detection of cognitive impairment in relapsing-remitting multiple sclerosis: functional-anatomical correlations and longitudinal follow-up].
    Bensa C; Bertogliati C; Chanalet S; Malandain G; Bedoucha P; Lebrun C
    Rev Neurol (Paris); 2006 Dec; 162(12):1221-31. PubMed ID: 17151514
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Cognitive dysfunction in patients with relapsing-remitting multiple sclerosis.
    Nocentini U; Pasqualetti P; Bonavita S; Buccafusca M; De Caro MF; Farina D; Girlanda P; Le Pira F; Lugaresi A; Quattrone A; Reggio A; Salemi G; Savettieri G; Tedeschi G; Trojano M; Valentino P; Caltagirone C
    Mult Scler; 2006 Feb; 12(1):77-87. PubMed ID: 16459723
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Cognitive impairment predicts disability progression and cortical thinning in MS: An 8-year study.
    Pitteri M; Romualdi C; Magliozzi R; Monaco S; Calabrese M
    Mult Scler; 2017 May; 23(6):848-854. PubMed ID: 27527906
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Using mental visual imagery to improve autobiographical memory and episodic future thinking in relapsing-remitting multiple sclerosis patients: A randomised-controlled trial study.
    Ernst A; Blanc F; De Seze J; Manning L
    Restor Neurol Neurosci; 2015; 33(5):621-38. PubMed ID: 26410206
    [TBL] [Abstract][Full Text] [Related]  

  • 92. In vivo evidence of hippocampal dentate gyrus expansion in multiple sclerosis.
    Rocca MA; Longoni G; Pagani E; Boffa G; Colombo B; Rodegher M; Martino G; Falini A; Comi G; Filippi M
    Hum Brain Mapp; 2015 Nov; 36(11):4702-13. PubMed ID: 26287572
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Cognitive impairment in patients suffering from relapsing-remitting multiple sclerosis with EDSS < or = 3.5.
    Ruggieri RM; Palermo R; Vitello G; Gennuso M; Settipani N; Piccoli F
    Acta Neurol Scand; 2003 Nov; 108(5):323-6. PubMed ID: 14616301
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [The value of certain static stabilometric characteristics].
    Likhachev SA; Kachinskiĭ AN
    Vestn Otorinolaringol; 2011; (2):33-7. PubMed ID: 21512483
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Isolated cognitive relapses in multiple sclerosis.
    Pardini M; Uccelli A; Grafman J; Yaldizli Ö; Mancardi G; Roccatagliata L
    J Neurol Neurosurg Psychiatry; 2014 Sep; 85(9):1035-7. PubMed ID: 24686566
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Cognitive functions and disability progression in relapsing-remitting multiple sclerosis: A longitudinal study.
    Heled E; Aloni R; Achiron A
    Appl Neuropsychol Adult; 2021; 28(2):210-219. PubMed ID: 31204507
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [The role of brain glucose metabolism in the development of cognitive dysfunctions in patients with remitting and secondary-progressive multiple sclerosis].
    Shkil'niuk GG; Il'ves AG; Kataeva GV; Prakhova LN; Reznikova TN; Seliverstova NA; Stoliarov ID
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(2 Pt 2):41-6. PubMed ID: 22677678
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Cognitive phenotypes in multiple sclerosis.
    Leavitt VM; Tosto G; Riley CS
    J Neurol; 2018 Mar; 265(3):562-566. PubMed ID: 29356970
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Cognitive function and oral health in relapsing-remitting multiple sclerosis.
    Manchery N; Henry JD; Swayne A; Beer R; Blum S; Nangle MR
    Clin Oral Investig; 2022 Mar; 26(3):2899-2907. PubMed ID: 34773142
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Acute verbal dyspraxia, a rare presentation in multiple sclerosis: a case report with MRI localization.
    Jaffe SL; Glabus MF; Kelley RE; Minagar A
    Mult Scler; 2003 Dec; 9(6):630-2. PubMed ID: 14664479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.